These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Trigocherrierin A, a potent inhibitor of chikungunya virus replication. Bourjot M; Leyssen P; Neyts J; Dumontet V; Litaudon M Molecules; 2014 Mar; 19(3):3617-27. PubMed ID: 24662077 [TBL] [Abstract][Full Text] [Related]
45. A combination of doxycycline and ribavirin alleviated chikungunya infection. Rothan HA; Bahrani H; Mohamed Z; Teoh TC; Shankar EM; Rahman NA; Yusof R PLoS One; 2015; 10(5):e0126360. PubMed ID: 25970853 [TBL] [Abstract][Full Text] [Related]
46. The effectiveness of antiviral agents with broad-spectrum activity against chikungunya virus varies between host cell lines. Franco EJ; Rodriquez JL; Pomeroy JJ; Hanrahan KC; Brown AN Antivir Chem Chemother; 2018; 26():2040206618807580. PubMed ID: 30354193 [TBL] [Abstract][Full Text] [Related]
47. In vitro antiviral activity of arbidol against Chikungunya virus and characteristics of a selected resistant mutant. Delogu I; Pastorino B; Baronti C; Nougairède A; Bonnet E; de Lamballerie X Antiviral Res; 2011 Jun; 90(3):99-107. PubMed ID: 21440006 [TBL] [Abstract][Full Text] [Related]
48. Characterization of β-d- Ehteshami M; Tao S; Zandi K; Hsiao HM; Jiang Y; Hammond E; Amblard F; Russell OO; Merits A; Schinazi RF Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137799 [TBL] [Abstract][Full Text] [Related]
49. Evaluation of medicinal herbs for Anti-CHIKV activity. Raghavendhar S; Tripati PK; Ray P; Patel AK Virology; 2019 Jul; 533():45-49. PubMed ID: 31082733 [TBL] [Abstract][Full Text] [Related]
50. Potential Antivirals: Natural Products Targeting Replication Enzymes of Dengue and Chikungunya Viruses. Oliveira AF; Teixeira RR; Oliveira AS; Souza AP; Silva ML; Paula SO Molecules; 2017 Mar; 22(3):. PubMed ID: 28327521 [TBL] [Abstract][Full Text] [Related]
51. Isolation of phenanthrenes and identification of phorbol ester derivatives as potential anti-CHIKV agents using FBMN and NAP from Sagotia racemosa. Remy S; Solis D; Silland P; Neyts J; Roussi F; Touboul D; Litaudon M Phytochemistry; 2019 Nov; 167():112101. PubMed ID: 31473556 [TBL] [Abstract][Full Text] [Related]
52. Structural Optimizations of Thieno[3,2-b]pyrrole Derivatives for the Development of Metabolically Stable Inhibitors of Chikungunya Virus. Ching KC; Tran TN; Amrun SN; Kam YW; Ng LF; Chai CL J Med Chem; 2017 Apr; 60(7):3165-3186. PubMed ID: 28350454 [TBL] [Abstract][Full Text] [Related]
54. In vitro Evaluation of Anti-Chikungunya Virus Activities of Tualang Honey. Barkhadle NI; Mohamud R; Mat Jusoh TNA; Shueb RH Trop Biomed; 2021 Mar; 38(1):42-49. PubMed ID: 33797523 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of Chikungunya virus by an adenosine analog targeting the SAM-dependent nsP1 methyltransferase. Mudgal R; Mahajan S; Tomar S FEBS Lett; 2020 Feb; 594(4):678-694. PubMed ID: 31623018 [TBL] [Abstract][Full Text] [Related]
56. Comparative analysis of the anti-chikungunya virus activity of novel bryostatin analogs confirms the existence of a PKC-independent mechanism. Abdelnabi R; Staveness D; Near KE; Wender PA; Delang L; Neyts J; Leyssen P Biochem Pharmacol; 2016 Nov; 120():15-21. PubMed ID: 27664855 [TBL] [Abstract][Full Text] [Related]
57. Discovery of Novel Peptidomimetics as Irreversible CHIKV NsP2 Protease Inhibitors Using Quantum Mechanical-Based Ligand Descriptors. El-labbad EM; Ismail MA; Abou Ei Ella DA; Ahmed M; Wang F; Barakat KH; Abouzid KA Chem Biol Drug Des; 2015 Dec; 86(6):1518-27. PubMed ID: 26212366 [TBL] [Abstract][Full Text] [Related]
59. In Vitro Inhibition of Alphaviruses by Lycorine. Li N; Wang Z; Wang R; Zhang ZR; Zhang YN; Deng CL; Zhang B; Shang LQ; Ye HQ Virol Sin; 2021 Dec; 36(6):1465-1474. PubMed ID: 34374926 [TBL] [Abstract][Full Text] [Related]